Saturday, July 31, 2021 12:15:50 AM
hyperopia, I believe the simple explanation for the change in language is due to Brexit. Up until 12/31/2020, the UK was part of the EU (European Union). So, NWBio could refer to all the EU, including the UK, collectively as the “European region”.
However, once the UK separated from the EU due to Brexit, effective 1/1/2021, the UK was no longer part of the EU. As a result, NWBio had to refer to the UK by itself, separately from the European region.
Also, other countries outside of the EU, but are in the area, like Switzerland, can be referred to as in “other regions. So, although Switzerland is in Europe, they are not in the EU. But, because Switzerland is 1 of the 6 participating Project Orbis countries, SwissMedic can still approve DCVax-L through the Project Orbis program. And, the Switzerland market can be serviced through Sawston, unless SwissMedic gives NWBio different requirements.
However, once the UK separated from the EU due to Brexit, effective 1/1/2021, the UK was no longer part of the EU. As a result, NWBio had to refer to the UK by itself, separately from the European region.
Also, other countries outside of the EU, but are in the area, like Switzerland, can be referred to as in “other regions. So, although Switzerland is in Europe, they are not in the EU. But, because Switzerland is 1 of the 6 participating Project Orbis countries, SwissMedic can still approve DCVax-L through the Project Orbis program. And, the Switzerland market can be serviced through Sawston, unless SwissMedic gives NWBio different requirements.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
